{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:20:19Z","timestamp":1793496019676,"version":"4.5.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Parkinson's disease (PD) is characterized by several motor and non-motor manifestations. These variable neurological complaints have diverse intensity and cause various degrees of disability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective methods<\/jats:title>\n                    <jats:p>We aimed to assess the top three most troublesome neurological complaints in patients with PD and correlated them with demographic and clinical variables, including the cognitive status assessed by the Montreal Cognitive Assessment (MoCA). Patients were asked about their three most troublesome neurological complaints after reviewing all motor and non-motor symptoms. Responses were divided into three tiers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We studied 230 consecutive patients with PD. There were 130 (56.5%) male patients, with the mean age at evaluation of 67.7 \u00b1 11.06 years. The most common neurological complaints in the top tier were (1) tremor (\n                      <jats:italic>n<\/jats:italic>\n                      = 80, 34.8%), (2) gait problems (\n                      <jats:italic>n<\/jats:italic>\n                      = 37, 16.1%), and (3) dyskinesia (\n                      <jats:italic>n<\/jats:italic>\n                      = 17, 7.4%). Speech difficulties, dyskinesia, and insomnia became more prominent 5 or 10 years after disease onset. A total of 159 (69.1%) patients reported \u201cat least one non-motor symptom\u201d among their top-3 tier complaints. Pain (\n                      <jats:italic>n<\/jats:italic>\n                      = 29, 12.6%), anxiety (\n                      <jats:italic>n<\/jats:italic>\n                      = 25, 10.8%), and insomnia (\n                      <jats:italic>n<\/jats:italic>\n                      = 25, 10.8%) were the most common non-motor symptoms. The presence of non-motor symptoms in the top three tiers was associated with decreased cognitive status (MoCA &amp;lt;25 points), but not with age, sex, or disease evolution time. Cognitive impairment was a significant predictor of non-motor symptoms in their top three tiers [odds ratio [OR]: 3.88 (95% CI: 1.647 to 9.169)]. Cluster analysis of patients with at least one non-motor symptom identified four groups: male or female patients with short evolution time, a postural-instability gait difficulty (PIGD) phenotype, and a dyskinetic group. The latter two were associated with a higher frequency of fatigue, insomnia, pain, and anxiety.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, tremor was the most troublesome symptom in patients with PD, though high variability was observed. Approximately 69% of patients had at least one non-motor symptom among their top-3 complaints, which was associated with abnormal cognitive status. Speech difficulties, dyskinesia, and insomnia became more prominent with disease progression. Among patients with non-motor symptoms in the top three tiers, those with a PIGD phenotype or prominent dyskinesia exhibited a higher frequency of fatigue, insomnia, pain, and anxiety, suggesting a clustering effect of non-motor symptoms with these motor presentations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2025.1664934","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:32:52Z","timestamp":1761111172000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Top motor and non-motor complaints in patients with Parkinson's disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Jos\u00e9 Fidel","family":"Baizabal-Carvallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Alonso-Juarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/mds.26281","article-title":"Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives","volume":"30","author":"Baig","year":"2015","journal-title":"Mov. Disord"},{"key":"B2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/1756285611411504","article-title":"Management of sexual dysfunction in Parkinson's disease","volume":"4","author":"Bronner","year":"2011","journal-title":"Ther. Adv. Neurol. Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.31083\/j.jin2205132","article-title":"Pain in Parkinson's disease: pathophysiology, classification and treatment","volume":"22","author":"Cattaneo","year":"2023","journal-title":"J. Integr. Neurosci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40120-024-00687-6","article-title":"Sex differences in Parkinson's disease: a narrative review","volume":"14","author":"Cattaneo","year":"2025","journal-title":"Neurol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/ane.12796","article-title":"Gender differences in Parkinson's disease: a clinical perspective","volume":"136","author":"Georgiev","year":"2017","journal-title":"Acta Neurol. Scand"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord"},{"key":"B7","doi-asserted-by":"publisher","first-page":"628","DOI":"10.3389\/fneur.2018.00628","article-title":"Impact of tremor on patients with early stage Parkinson's disease","volume":"9","author":"Heusinkveld","year":"2018","journal-title":"Front. Neurol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B10","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.parkreldis.2017.02.024","article-title":"Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers","volume":"38","author":"Maeda","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"B12","doi-asserted-by":"publisher","first-page":"7203259","DOI":"10.1155\/2017\/7203259","article-title":"Stigma experienced by parkinson's disease patients: a descriptive review of qualitative studies","volume":"2017","author":"Maffoni","year":"2017","journal-title":"Parkinsons. Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JPD-225068","article-title":"Relative meaningfulness and impacts of symptoms in people with early-stage Parkinson's disease","volume":"13","author":"Mammen","year":"2023","journal-title":"J. Parkinsons. Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21171","DOI":"10.1038\/s41598-024-71555-4","article-title":"Understanding what aspects of Parkinson's disease matter most to patients and families","volume":"14","author":"Mammen","year":"2024","journal-title":"Sci. Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.dadm.2018.09.003","article-title":"Optimal cutoffs for the Montreal Cognitive Assessment vary by race and ethnicity","volume":"10","author":"Milani","year":"2018","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00415-013-7085-x","article-title":"Gender differences in non-motor symptoms in early, drug na\u00efve Parkinson's disease","volume":"260","author":"Picillo","year":"2013","journal-title":"J. Neurol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson's disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","article-title":"Parkinson's disease symptoms: the patient's perspective","volume":"25","author":"Politis","year":"2010","journal-title":"Mov. Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JPD-202346","article-title":"People with parkinson's disease: what symptoms do they most want to improve and how does this change with disease duration?","volume":"11","author":"Port","year":"2021","journal-title":"J. Parkinsons. Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/mdc3.12921","article-title":"Levodopa equivalent dose conversion factors: an updated proposal including opicapone and safinamide","volume":"7","author":"Schade","year":"2020","journal-title":"Mov. Disord. Clin. Pract"},{"key":"B22","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3233\/JPD-202457","article-title":"Patient-centered conceptual model of symptoms and their impact in early Parkinson's disease: a qualitative study","volume":"12","author":"Staunton","year":"2022","journal-title":"J. Parkinsons. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fneur.2018.00170","article-title":"Non-motor symptoms of Parkinson's disease and their impact on quality of life in a cohort of moroccan patients","volume":"9","author":"Tibar","year":"2018","journal-title":"Front. Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6067132","DOI":"10.1155\/2016\/6067132","article-title":"Classification and characteristics of pain associated with Parkinson's disease","volume":"2016","author":"Young Blood","year":"2016","journal-title":"Parkinsons. Dis"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1664934\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:32:53Z","timestamp":1761111173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1664934\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":24,"alternative-id":["10.3389\/fnagi.2025.1664934"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1664934","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"article-number":"1664934"}}